However, in breast cancer miR-373 appears to have tumor suppressor activity, as re-expression of miR-373 inhibited TGF-β-induced invasion in MDA-MB-231 and MCF10A cells as well as vascular intravasation in ER− breast cancer in vivo [19]. This evidence concerns the gene TGFB1 and breast carcinoma.